Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments

Treatment of FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML) remains a challenge despite the development of novel FLT3-directed tyrosine kinase inhibitors (TKI); the relapse rate is still high even after allogeneic stem cell transplantation....

全面介紹

書目詳細資料

Principais autores:	Sebastian Scholl, Maximilian Fleischmann, Ulf Schnetzke, Florian H. Heidel
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2020-11-01
叢編:	Cells
主題:	acute myeloid leukemia AML FMS-like tyrosine kinase 3 FLT3 FLT3-ITD FLT3-TKD
在線閱讀:	https://www.mdpi.com/2073-4409/9/11/2493
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!